Definium Therapeutics is a late-stage clinical biopharmaceutical company focused on developing accessible treatments for psychiatric disorders using psychedelics. Our lead candidate, lysergide tartrate, targets generalized anxiety, major depressive disorder, and posttraumatic stress disorder. We are also developing DT402 for the core symptoms of autism spectrum disorder. Our mission is to advance psychiatry beyond current standards and address the root causes of psychiatric and neurological disorders. Headquartered in New York and trading on Nasdaq (DFTX), we are committed to transforming mental health care.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior